Psychoactive Drugs - GEN - Genetic Engineering and Biotechnology News

neural network transmission

Psychoactive Drugs

Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform

Psychoactive Drugs

Opposing Activities of Serotonin-Producing Neurons Hint at Strategies for Treating Addictions, Depression

Abstract human profiles with puzzle pieces

Psychoactive Drugs

No Hallucination: The Launch of Psychedelic Medicine

Laboratory technician holding daily dose in a micro tube

Psychoactive Drugs

Reach for the Sky: Empyrean Neuroscience Launches to Treat CNS Disorders with Genetically Engineered Neuroactive Medicines

mock patient in bed

Translational Medicine

Transforming Psychedelics into Approved Medicines

Young man facing the camera looking worried.

Psychoactive Drugs

Compounds Designed to Target LSD Receptor but Without Hallucinations

depression

Psychoactive Drugs

Pharmacogenetic Testing May Help When Prescribing Antidepressants

Psychoactive Drugs

If Your New Year’s Hangover Remedy Failed, You’re Not Alone

Silhouette Boy Standing By Stairs At Home

Psychoactive Drugs

Oxytocin Gene Methylation and Brain Development Impacted by Child Abuse

Anxiety, Depression, Mental Illness

Psychoactive Drugs

Trial Indicates Constipation Therapy May Be Used to Improve Cognition in...

Psychoactive Drugs

Dual Drug Therapy for Alcohol Use Disorder Addresses Existing Treatment Side...

Source: gilaxia/Getty Images

Psychoactive Drugs

Psychedelic Compound in “Magic Mushrooms” Prompts Growth of Neural Connections Lost...

Psychoactive Drugs

Antidepressant Withdrawal Syndrome Linked to Membrane Lipid Raft Signaling

Three Mice at the Ends of Their Ropes

Psychoactive Drugs

Psychedelic Analog Restores Calm (and Neural Circuits) in Stressed Out Mice

Psychoactive Drugs

Psychedelic-Like Drug Lacking Hallucinogenic Side Effects Identified with New Sensor

12 3 4 Page 1 of 4